ASCIA Action, First Aid, Management, Travel and Treatment Plans and Guides
ASCIA Action Plans for Anaphylaxis (RED)
Current ASCIA Action Plans are the General and EpiPen 2021 versions, and the 2022 Anapen version. However, prior versions (2021, 2020 and 2018) are still valid for use in 2022 and 2023. ASCIA Action Plans do not expire, and therefore the plan is still valid beyond the date of review, which is a guide for patients to see their doctor. For further information about ASCIA Action Plans go to www.allergy.org.au/hp/anaphylaxis/action-plans-for-allergic-reactions-faq
ASCIA Action Plan for Anaphylaxis (RED) 2021 EpiPen®
This plan is provided to people with allergies who have been prescribed EpiPen® adrenaline injectors.
This plan is not for allergic rhinitis (hay fever) due to pollen, dust mite, animals or other inhaled allergens.
ASCIA Action Plan for Anaphylaxis (RED) 2022 Anapen®
This plan is provided to people with allergies who have been prescribed Anapen® adrenaline injectors.
This plan is not for allergic rhinitis (hay fever) due to pollen, dust mite, animals or other inhaled allergens.
ASCIA Action Plan for Anaphylaxis (RED) 2021 General with QR Code
This plan is provided to people with allergies who have been prescribed any brand of adrenaline injectors.
This plan is not for allergic rhinitis (hay fever) due to pollen, dust mite, animals or other inhaled allergens.
How to give adrenaline injectors (Anapen® and EpiPen®)
This document can be printed as a poster, and used with the generic versions of ASCIA Action Plans or First Aid Plans for Anaphylaxis.
ASCIA Action Plan for Drug (Medication) Allergy
This plan is provided to people with drug (medication) allergies who are not usually prescribed an adrenaline injector, because accidental exposure to drugs can mostly be avoided. They are usually recommended to wear medical identification, to avoid exposure to drugs used in medical procedures.
An ASCIA Action Plan for Anaphylaxis for use with adrenaline autoinjectors on airlines is available upon request. This plan is should be stored with adrenaline autoinjectors in emergency medical kits on airlines.
ASCIA First Aid Plans for Anaphylaxis (ORANGE)
Note: These have replaced the general versions of ASCIA Action Plans for Anaphylaxis (ORANGE)
ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2021 EpiPen®
This plan can be used as a poster or stored with general use EpiPen® adrenaline autoinjectors.
ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2022 Anapen®
This plan can be used as a poster or stored with general use Anapen® adrenaline autoinjectors.
ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2021 General with QR Code
This plan can be used as a poster or stored with general use adrenaline autoinjectors.
ASCIA First Aid Anaphylaxis General Orange 2021 with QR Code
ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2021 Pictorial Poster
The ASCIA Action Plan is best viewed when printed as an A3 poster.
For translated versions of ASCIA First Aid for Anaphylaxis go to www.allergy.org.au/hp/anaphylaxis#ta5
For further information about ASCIA Action Plans and other anaphylaxis resources go to www.allergy.org.au/anaphylaxis
ASCIA Travel Plan for people at risk of anaphylaxis
ASCIA Travelling with allergy, asthma and anaphylaxis checklist
ASCIA Checklist: Travelling with allergy, asthma or anaphylaxis 2021
ASCIA Action Plan for Eosinophilic Oesophagitis (EoE) and Management Plan Eosinophilic Oesophagitis (EoE)
ASCIA Action Plan for FPIES (food protein-induced enterocolitis syndrome)
ASCIA SCIg (subcutaneous immunoglobulin) Treatment Plan
ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy)
ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy)
ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy
ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy
Content updated December 2022
ASCIA Action Plans,
Treatment Plans and
Checklists
Site last updated: 4 May 2023
About ASCIA
ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...
The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...
Disclaimer I Privacy
The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...
ASCIA respects your privacy. Read our privacy policy here...
Sponsors | Advertising
ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.
The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.
Information Partner
